Clinical Trials for Recurrent Follicular Lymphoma

Find clinical trials for recurrent follicular lymphoma. Discover research opportunities and treatment options in your area.

8 Active Trials Found

Showing 8 trials on this page

Page 1 of 1

Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment

NCT ID: NCT05627245

This clinical trial is investigating the safety and effectiveness of two anti-cancer drugs, tazemetostat and belinostat, for patients with certain types of lymphomas that have come back after treat...

Recruiting

Phase: PHASE1 Type: interventional Locations: New Haven, Connecticut, United States, Oklahoma City, Oklahoma, United States +8 more

Q702 for the Treatment of Patients With Hematologic Malignancies

NCT ID: NCT06712810

This clinical trial is studying a new medication called Q702 to see how safe it is and how well it works for people with certain types of blood cancers, known as hematologic malignancies. These can...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Scottsdale, Arizona, United States, Rochester, Minnesota, United States

Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma

NCT ID: NCT03147885

This clinical trial is studying a new treatment approach for patients with advanced B-cell non-Hodgkin lymphoma, including types like diffuse large B-cell lymphoma and others. The trial combines a ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Detroit, Michigan, United States, La Jolla, California, United States

Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial

NCT ID: NCT06948786

The PROMOTE-FL trial is a clinical study looking at two medications, pirtobrutinib and mosunetuzumab, to see how well they work together in treating patients with grades 1-3a follicular lymphoma (F...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

NCT ID: NCT04587687

This clinical trial is studying the combination of two treatments, brentuximab vedotin and bendamustine, to see how effective they are for patients with follicular lymphoma that has either returned...

Recruiting

Phase: PHASE2 Type: interventional Locations: Sacramento, California, United States

Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell Malignancies

NCT ID: NCT05453396

This clinical trial is studying a new treatment called loncastuximab tesirine for patients with specific types of B-cell cancers that have either come back after previous treatments or did not resp...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies

NCT ID: NCT06191887

This clinical trial is investigating a new treatment approach for patients with certain types of blood cancers that have returned after treatment or have not responded well to previous therapies. T...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jacksonville, Florida, United States

Efficacy of Palliative Low-Dose Involved-Field Radiation Therapy for Recurrent Advanced Follicular Lymphoma

NCT ID: NCT02438501

This clinical trial is studying the effects of a special type of low-dose radiation therapy called low-dose involved-field radiation therapy (LD-IFRT) for patients with recurrent advanced follicula...

Recruiting

Phase: PHASE3 Type: interventional Locations: Wuhan, Hubei, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions